Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

REGN - Regeneron Pharmaceuticals, Inc.


IEX Last Trade
1184.19
5.260   0.444%

Share volume: 405,349
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$1,178.93
5.26
0.45%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-11-03 2023-02-06 2023-05-04 2023-08-03 2023-11-02 2024-02-05 2024-05-02 2024-08-01
Assets
Total Assets 27.678 B 29.215 B 30.060 B 30.658 B 32.163 B 33.080 B 34.370 B 36.087 B
Current Assets 15.429 B 15.884 B 16.909 B 16.923 B 18.635 B 19.479 B 18.872 B 19.082 B
Inventories 2.412 B 2.402 B 2.425 B 2.508 B 2.562 B 2.581 B 2.715 B 2.874 B
Other Current Assets 446.400 M 411.200 M 406.200 M 366.300 M 574.700 M 386.600 M 414.900 M 681.900 M
Short Term Investments 446.400 M 411.200 M 406.200 M 366.300 M 574.700 M 386.600 M 414.900 M 681.900 M
Total Receivables 5.548 B 5.329 B 5.119 B 5.121 B 5.585 B 5.667 B 5.222 B 5.717 B
Current Cash 7.022 B 7.742 B 8.960 B 8.928 B 9.914 B 10.845 B 10.520 B 9.809 B
Total Non-current Assets 12.249 B 13.330 B 13.151 B 13.735 B 13.529 B 13.601 B 15.498 B 17.005 B
Property Plant Equipment 3.704 B 3.763 B 3.881 B 3.923 B 4.006 B 4.146 B 4.226 B 4.306 B
Other Assets 320.200 M 336.400 M 349.600 M 393.200 M 409.900 M 444.100 M 470.200 M 993.800 M
Intangible Assets 804.100 M 915.500 M 928.700 M 953.000 M 1.017 B 1.039 B 1.059 B 1.102 B
Goodwill 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 27.678 B 29.215 B 30.060 B 30.658 B 32.163 B 33.080 B 34.370 B 36.087 B
Total liabilities 6.239 B 6.551 B 6.565 B 6.640 B 7.259 B 7.107 B 7.379 B 7.881 B
Total current liabilities 2.879 B 3.141 B 3.100 B 3.104 B 3.599 B 3.423 B 3.581 B 3.509 B
Accounts Payable 535.600 M 589.200 M 599.500 M 547.300 M 536.600 M 606.600 M 671.300 M 561.700 M
Other liabilities 658.700 M 707.800 M 762.800 M 833.000 M 957.700 M 980.800 M 1.094 B 1.669 B
Current long term debt 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Long term debt 2.701 B 2.701 B 2.702 B 2.702 B 2.703 B 2.703 B 2.703 B 2.704 B
Other liabilities 658.700 M 707.800 M 762.800 M 833.000 M 957.700 M 980.800 M 1.094 B 1.669 B
Minority interest 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Total Shareholder equity 21.439 B 22.664 B 23.495 B 24.018 B 24.904 B 25.973 B 26.991 B 28.206 B
Common stock 106.900 M 106.800 M 107.100 M 107.000 M 106.300 M 106.400 M 107.800 M 108.100 M
Retained earnings 22.110 B 23.307 B 24.125 B 25.093 B 26.101 B 27.260 B 27.982 B 29.415 B